Emmanuelle Charpentier

Emmanuelle Charpentier
Emmanuelle Charpentier
	Charpentier in 2015
Born	Emmanuelle Marie Charpentier; 11 December 1968; Juvisy-sur-Orge, France
Education	Pierre and Marie Curie University (BSc MSc, DPhil); Pasteur Institute (PhD training)
Known for	CRISPR
Awards	Louis-Jeantet Prize for Medicine (2015); Breakthrough Prize in Life Sciences (2015); Princess of Asturias Award (2015); Tang Prize in Biopharmaceutical Science (2016); Canada Gairdner International Award (2016); Leibniz Prize (2016); Pour le Mérite (2017); Japan Prize (2017); The Novozymes Prize (2017); Kavli Prize in Nanoscience (2018); Wolf Prize in Medicine (2020); Nobel Prize in Chemistry (2020);
	Scientific career
Fields	Microbiology; Genetics; Biochemistry; CRISPR-Cas;
Institutions	University of Berlin; Umeå University; Max Planck Society
Thesis	Antibiotic resistance in Listeria spp (1995)
Doctoral advisor	Patrice Courvalin
Website	www.emmanuelle-charpentier-pr.org

Emmanuelle Marie Charpentier (French: [ɛmanɥɛl ʃaʁpɑ̃tje]; born 11 December 1968) is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing" (through CRISPR). This was the first science Nobel Prize ever won by two women only.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.